Navigation Links
NOVAVAX Announces Issuance of Key U.S. Patent for Influenza Virus-Like Particle (VLP) Vaccines
Date:7/27/2010

ROCKVILLE, Md., July 27 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX) announced today the issuance of U.S. Patent No. 7,763,450 for "Functional Influenza Virus-Like Particles (VLPS)".  The patent covers the use of influenza gene sequences for high-yield production of consistent influenza VLP vaccines to protect against current and future seasonal and pandemic strains of influenza viruses.

Novavax's newly patented influenza vaccine technology utilizes hemagglutinin (HA) and neuraminidase (NA), major proteins found on the surface of the influenza virus together with a single influenza matrix 1 (M1) protein, to form the core of the influenza VLP.  As new influenza strains emerge, Novavax's technology allows HA and NA to be engineered to match strains recommended by U.S. and world health regulatory authorities and then combined with a universal M1 protein.  Novavax has identified an M1 protein that efficiently forms VLPs from multiple influenza strains, including the human A and B strains that are currently responsible for the disease world wide.  This process promotes rapid and efficient production of VLPs that have a more uniform shape and size, which Novavax believes will add to the consistency and safety of its vaccines.

"Our VLP technology overcomes a major limitation of the current influenza virus vaccine technology that depends on strain selection and optimization every year.  It enables faster production of vaccine for the target influenza strain than the existing, egg-based process which resulted in significant delays in the manufacture of vaccines during the 2009 H1N1 pandemic emergency," said Dr. Gale Smith, Vice President of Vaccine Development
'/>"/>

SOURCE Novavax, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Novavax CEO to Present at Phacilitate Vaccine Forum Barcelona 2010
2. Novavaxs Seasonal Influenza VLP Vaccine Candidate Shows Positive Results in a Phase II Clinical Trial in Older Adults
3. NOVAVAX Reports Fourth Quarter and 2009 Year-End Financial Results
4. NOVAVAX to Present at 22nd Annual ROTH OC Growth Stock Conference
5. NOVAVAX to Present at Cowen and Companys 30th Annual Health Care Conference
6. NOVAVAX Reports Additional Positive Data from Its Trivalent Seasonal Influenza (VLP) Vaccine Clinical Study in Healthy Adults
7. Novavax Terminates Negotiations with ROVI Pharmaceuticals for Influenza Vaccine Collaboration
8. NOVAVAX Announces Closing of Public Offering of 6,800,000 Shares of Common Stock
9. NOVAVAX Reports Positive Clinical Results from Pivotal Study of H1N1 Influenza Vaccine in Mexico
10. Novavax to Present at 8th Annual BIO Investor Forum 2009
11. Novavax Launches Pivotal Clinical Study of Novel 2009 H1N1 VLP Flu Vaccine in Mexico
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/29/2015)... 2015 Educating the community continues to ... the Advancement of Wound Care (AAWC), which was ... AAWC,s corporate partners, the Association provides medical professionals ... AAWC website at http://aawconline.org/education-for-the-generalist/ . The portal ... links to various CME/CEU educational programs. This education ...
(Date:5/28/2015)... HOUSTON , May 28, 2015 /PRNewswire/ - ESSA Pharma ... results for the second quarter and three and six months ... in Canadian dollars and in accordance with International Financial Reporting ... ESSA recorded a net loss of $5.9 million ($0.35 per ... (Q2-2015), compared to a net loss of $0.4 million ($0.03 ...
(Date:5/28/2015)... 2015  Maetrics ( http://maetrics.com ), a leading international ... up a successful conference, "The cost of non-compliance -- How ... in Zurich . ... Switzerland -based team, experts provided insights ... field to an exclusive local audience. The event was ...
Breaking Medicine Technology:The Association for the Advancement of Wound Care Educates the Public 2Essa Pharma Inc. Reports Second Quarter 2015 Financial Results 2Essa Pharma Inc. Reports Second Quarter 2015 Financial Results 3Essa Pharma Inc. Reports Second Quarter 2015 Financial Results 4Essa Pharma Inc. Reports Second Quarter 2015 Financial Results 5Maetrics Hosts Innovative Medical Cluster Event in Switzerland 2
... 5 GlaxoSmithKline [NYSE: GSK] today announced that ... Oncologic Drugs Advisory Committee (ODAC) voted unanimously in ... the panel voted that the benefit-to-risk profile is ... (RCC). Pazopanib is an investigational, oral treatment for ...
... Oct. 5 In a settlement that is essentially ... (NLRB), which conducted a two-month investigation into massive illegal ... company, the giant HCA chain, have pledged to end ... of registered nurses. , The settlement stems from a ...
Cached Medicine Technology:GlaxoSmithKline Receives Unanimous FDA Panel Approval Recommendation for VOTRIENT(TM) 2GlaxoSmithKline Receives Unanimous FDA Panel Approval Recommendation for VOTRIENT(TM) 3Faced With Federal Prosecution, MountainView Agrees to Stop Harassment of RNs in Settlement With Labor Board 2
(Date:5/29/2015)... Intermountain Healthcare of Salt ... Stratus Video Interpreting for on-demand medical ... and timely care for patients with limited ... video remote interpreting (VRI) services will supplement ... quickly access qualified medical interpretation in nearly ...
(Date:5/29/2015)... York, NY (PRWEB) May 29, 2015 ... USA Today, with a circulation of approximately 250,000 and ... distributed nationally, through a vast social media strategy, and ... outlets. To explore the digital version of the campaign, ... cover of the print publication. Inside, the actress, model ...
(Date:5/29/2015)... Mediaplanet has joined forces with Colorescience ... Skin Health is a cross-platform campaign with a national ... New York, Los Angeles, and Chicago, the campaign is ... counterpart will reach a national audience through one of ... Skin Health campaign and Colorescience, click here . ...
(Date:5/29/2015)... May 29, 2015 OncLive proudly announces ... dozen medical pioneers recognized by a panel of eminent ... of cancer treatment. Honorees will be introduced and celebrated ... Award Ceremony, held 8:30-11:00 p.m. CDT at The Chicago ... honorees are being recognized for groundbreaking accomplishments, in fields ...
(Date:5/29/2015)... May 29, 2015 Healthpointe is ... with specialists, physical therapy, and injections , For ... back and/or lower back pain, Healthpointe has a ... for herniated discs, disc protrusions and other causes ... , Healthpointe’s team of renowned surgeons are now ...
Breaking Medicine News(10 mins):Health News:Stratus Video Interpreting Partners With Intermountain Healthcare to Provide On-Demand Interpretation Services for Patients With Limited English Proficiency (LEP) 2Health News:Stratus Video Interpreting Partners With Intermountain Healthcare to Provide On-Demand Interpretation Services for Patients With Limited English Proficiency (LEP) 3Health News:Stratus Video Interpreting Partners With Intermountain Healthcare to Provide On-Demand Interpretation Services for Patients With Limited English Proficiency (LEP) 4Health News:Mediaplanet Launches “Skin Health” Campaign Featuring Colorescience 2Health News:OncLive's 2015 Giants of Cancer Care™ Awards Announced Today 2Health News:OncLive's 2015 Giants of Cancer Care™ Awards Announced Today 3Health News:OncLive's 2015 Giants of Cancer Care™ Awards Announced Today 4Health News:Healthpointe’s Pain Management Specialists Now Providing Lumbar Epidural Injections in Los Angeles County 2Health News:Healthpointe’s Pain Management Specialists Now Providing Lumbar Epidural Injections in Los Angeles County 3
... Researchers from Harvard School of Public Health (HSPH), Massachusetts ... Research (NBER), and Providence Health & Services have found ... increases health care use, reduces financial strain on covered ... is the first study to evaluate the impact of ...
... today [Thursday 7 July] at the Annual Scientific Meeting of ... the Academic Unit of Primary Health Care, University of Bristol. ... 2008, uses HPV vaccine that is effective against the two ... offers 70 per cent protection against cervical cancer. However, ...
... 6, 2011) One consequence of the expanded access to ... shortfall in the necessary numbers of physicians and other advanced ... issue of the Journal of the American College of ... the combined workforce of physicians, advance practice nurses, and physician ...
... HealthDay Reporter , WEDNESDAY, July 6 (HealthDay ... multiple sclerosis have been dimmed by recent research in ... found no support for prior studies connecting breast-feeding with ... disorder commonly known as MS. Instead, they ...
... , WEDNESDAY, July 6 (HealthDay News) -- Airline pilots ... debilitating fatigue that could hamper their flying performance, a ... U.S. Federal Aviation Administration should find ways to reduce ... to the report from the U.S. National Research Council. ...
... HealthDay Reporter , WEDNESDAY, July 6 (HealthDay News) -- ... rise in various parts of the country, and this one ... by a microscopic parasite that attacks blood cells, causing flu-like ... Lyme disease, which is caused by bacteria, babesia microti parasites ...
Cached Medicine News:Health News:Medicaid increases use of health care, decreases financial strain, improves health 2Health News:Medicaid increases use of health care, decreases financial strain, improves health 3Health News:Lack of clarity about HPV vaccine and the need for cervical cancer screening 2Health News:Future labor shortfalls of medical professionals predicted due to new demands of health-care reform 2Health News: Breast-Feeding May Not Protect Moms Against MS Relapse 2Health News: Breast-Feeding May Not Protect Moms Against MS Relapse 3Health News:Long Commutes for Pilots May Hamper Flying Performance: Study 2Health News:Long Commutes for Pilots May Hamper Flying Performance: Study 3Health News:Long Commutes for Pilots May Hamper Flying Performance: Study 4Health News:A Deadly New Reason to Avoid Deer Ticks 2Health News:A Deadly New Reason to Avoid Deer Ticks 3
... mg/kg sulfate (SO 4 ) ≤ 1000 mg/kg Cation ... Co ≤ 5 mg/kg Cr ≤ 10 mg/kg Cu ... 5 mg/kg Mg ≤ 5 mg/kg Mn ≤ 5 ... Pb ≤ 5 mg/kg Zn ≤ 5 mg/kg Special ...
Inquire...
... A low temperature agarose for special ... Optimal for in-gel restriction digestion/ligation and DNA ... manageable clear gel that provides excellent resolution ... 65°C and remains fluid at 37°C for ...
... Agarose 3:1 HRB™ (High Resolution Blend), ... to provide high resolution of small nucleic ... analysis of DNA fragmanets less than 1,000 ... patterns without smearing of high background fluorescence. ...
Medicine Products: